Financial statements Bionest
Balance sheet data of BIONEST
Year
|
2021
|
2022
|
---|---|---|
Total assets | 1 914 520,29 | 2 384 592,41 |
A. Fixed assets | 349 070,46 | 191 924,69 |
B. Current assets | 1 565 449,83 | 2 192 667,72 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 |
Total liabilities | 1 914 520,29 | 2 384 592,41 |
A. Equity | 784 697,60 | 914 349,95 |
B. Liabilities and provisions for liabilities | 1 129 822,69 | 1 470 242,46 |
I. Long-term liabilities | 335 661,40 | 0,00 |
II. Short-term liabilities | 794 161,29 | 1 470 242,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.